Login

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer 2024 pay Source
David R. Parkinson Also a director
President and CEO
Title from the Form 4 dated Oct 9, 2025
$4,057,237
David S. Wood
Chief Financial Officer
Title from the Form 4 dated Oct 9, 2025
$1,655,542

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
10
serving now
Independent
9 of 10
stated in the proxy
CEO also chairs the board
No
Richard Glickman
Director Independent Committees Other public boards 2024 pay Source
Richard Glickman
Independent
Compensation Committee
Eupraxia Pharmaceuticals Inc., enGene Holdings Inc. $707,644
David R. Parkinson
Not independent None stated None stated Paid as CEO
Gary Sollis
Independent
Audit Committee
None stated $504,388
Franklin M. Berger
Independent None stated Atea Pharmaceuticals Inc., Kezar Life Sciences Inc., Satellos Bioscience Inc. $504,388
Scott Requadt
Independent
Compensation Committee · Chair
None stated $501,388
Sanford Zweifach
Independent None stated Compugen Ltd., Carisma Therapeutics Inc. $502,388
Alex Martin
Independent
Compensation Committee
None stated $492,388
Marella Thorell
Independent
Audit Committee · Chair
Carisma Therapeutics Inc. $502,138
Philip Kantoff
Independent None stated Context Therapeutics Inc. $489,388
Lauren Merendino
Independent None stated None stated $265,444

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Jan 22, 2025 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support